Yüklüyor......
Hypertrophic Cardiomyopathy Mutations in MYBPC3 Dysregulate Myosin: Implications for Therapy
The mechanisms by which truncating mutations in MYBPC3 (encoding cardiac myosin binding protein-C; cMyBPC) or myosin missense mutations cause hyper-contractility and poor relaxation in hypertrophic cardiomyopathy (HCM) are incompletely understood. Using genetic and biochemical approaches we explored...
Kaydedildi:
| Yayımlandı: | Sci Transl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7184965/ https://ncbi.nlm.nih.gov/pubmed/30674652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aat1199 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|